Can early-stage bladder cancer be cured?

Written by Hu Zhong Dong
Medical Oncology
Updated on February 26, 2025
00:00
00:00

Bladder cancer is a relatively common malignant tumor in the urinary system and tends to occur more frequently in males, with the incidence rate being three to four times higher than that in females. Painless hematuria is likely to be caused by bladder cancer. Therefore, it is crucial to be cautious when hematuria occurs and to seek medical examination at a hospital as soon as possible, such as urinalysis and bladder ultrasound exams, which are non-invasive and relatively inexpensive. Early-stage bladder cancer can potentially be cured, especially if it is superficial. However, patients with poorly differentiated and highly malignant forms may undergo infusion chemotherapy and immunotherapy. Studies have shown that patients with minor bladder cancer, after undergoing systematic treatment, have a relatively high five-year survival rate.

Other Voices

doctor image
home-news-image
Written by Wang Jian
Urology
52sec home-news-image

Is bladder cancer scary?

Bladder cancer is the most common malignant tumor in urological surgery, primarily occurring in the bladder mucosa. Its symptoms include painless, intermittent gross hematuria, with nearly 100% of patients experiencing blood in the urine. The presence of hematuria should highly raise the suspicion of bladder cancer, and the examinations mainly include routine urinalysis and an ultrasound of the urinary system. Bladder cancer is not to be feared if it is detected and treated early. The surgery can be relatively simple, and minimally invasive treatment through the urethra, such as plasma electrosection or laser excision, is possible. Since bladder cancer can recur, postoperative management should include bladder perfusion therapy and regular cystoscopy re-examinations. Thus, bladder cancer is not to be feared, as early detection and treatment can lead to a cure.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
59sec home-news-image

The most common clinical manifestations of bladder cancer

The most common clinical manifestations of bladder cancer include: one initial clinical presentation is hematuria, which typically appears as painless, intermittent gross hematuria, sometimes it can also manifest as microscopic hematuria. The hematuria may occur only once or last from one day to several days, and it can subside or stop on its own. The color of the hematuria can be light red, possibly dark brown, generally dark red. The amount of bleeding and the duration of the hematuria are not necessarily proportional to the malignancy degree, size, scope, and number of the tumor. Additionally, bladder cancer patients can experience symptoms of bladder irritation, such as frequent urination, urgent urination, painful urination, and difficulties in urination, etc.

doctor image
home-news-image
Written by Liu Liang
Oncology
40sec home-news-image

What are the symptoms of bladder cancer?

Bladder cancer's most common symptom is a consistent presence of painless gross hematuria. Some patients also exhibit frequent urination, urgency, and pain during urination as initial signs of bladder irritation. In advanced local stages, palpable pelvic tumors can be detected in patients, with symptoms such as urinary retention, lower abdominal pain, and inability to urinate. In the late stages of bladder cancer, patients may experience weight loss, back and flank pain, and signs of renal failure among other clinical manifestations.

doctor image
home-news-image
Written by Liu Liang
Oncology
24sec home-news-image

How is bladder cancer caused?

The causes of bladder cancer are not very clear so far, and they are related to factors such as environment, genetics, and lifestyle habits. However, two major risk factors are quite clear: one is smoking, and the other is long-term exposure to aromatic amines, which are occupational factors that are significant risks for causing bladder cancer.

doctor image
home-news-image
Written by Liu Mei Fen
Medical Oncology
1min 4sec home-news-image

What is the best medicine for bladder cancer infusion?

Bladder perfusion chemotherapy involves infusing chemotherapy drugs directly into the bladder through a catheter to control tumor growth and reduce the recurrence rate after surgery. Generally, the drugs with significant effects on bladder perfusion fall into three categories. The first category is the anthracyclines, including doxorubicin, epirubicin, and pirarubicin. The second category includes platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin. The third category is vinorelbine. According to current big data research, vinorelbine bladder perfusion tends to have a lower recurrence rate. Without postoperative bladder perfusion chemotherapy, 60%-70% of patients will eventually experience recurrence. With bladder perfusion chemotherapy, the recurrence rate can be reduced to 20%-30%.